Package 57664-808-18

{"route": ["ORAL"], "spl_id": "23fd1e2c-9a41-54f3-e063-6394a90aeddb", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["92e98c47-abba-4018-99b6-a1fffed6db8b"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (57664-808-18)", "package_ndc": "57664-808-18", "marketing_start_date": "20170724"}, {"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (57664-808-88)", "package_ndc": "57664-808-88", "marketing_start_date": "20170724"}], "brand_name": "Phenytoin Sodium", "product_id": "57664-808_23fd1e2c-9a41-54f3-e063-6394a90aeddb", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "57664-808", "generic_name": "Phenytoin Sodium", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20170724", "listing_expiration_date": "20261231"}